Short answer
Tvardi Therapeutics, Inc. (TVRD) filed an 8-K current report with the SEC on March 6, 2026 reporting Item 8.01 (Other Events). 2026 Annual Meeting set for June 9, 2026.
Tvardi Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- 2026 Annual Meeting set for June 9, 2026
- Rule 14a-8 stockholder proposal deadline: March 16, 2026
- Advance notice deadline for board nominations and other proposals: March 16, 2026
- Universal proxy rule (Rule 14a-19) notice deadline for contested director nominations: April 10, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tvardi Therapeutics, Inc. 8-K filings
Get the next TVRD 8-K as it lands
Follow TVRD for push alerts, or ask the research agent what this filing means.